181 related articles for article (PubMed ID: 29943387)
1. Plasma levels of free fatty acids correlate with type 2 diabetes mellitus.
Spiller S; Blüher M; Hoffmann R
Diabetes Obes Metab; 2018 Nov; 20(11):2661-2669. PubMed ID: 29943387
[TBL] [Abstract][Full Text] [Related]
2. Effect of augmented glycation in mobilization of plasma free fatty acids in type 2 diabetes mellitus.
Chandra K; Jain V; Azhar M; Khan W; Alam O; Ahmad S; Jain SK
Diabetes Metab Syndr; 2020; 14(5):1385-1389. PubMed ID: 32755839
[TBL] [Abstract][Full Text] [Related]
3. Association between serum free fatty acid levels and possible related factors in patients with type 2 diabetes mellitus and acute myocardial infarction.
Lv ZH; Ma P; Luo W; Xiong H; Han L; Li SW; Zhou X; Tu JC
BMC Cardiovasc Disord; 2014 Nov; 14():159. PubMed ID: 25399059
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Accuracy of Protein Glycation Sites in Long-Term Controlled Patients with Type 2 Diabetes Mellitus and Their Prognostic Potential for Early Diagnosis.
Spiller S; Li Y; Blüher M; Welch L; Hoffmann R
Pharmaceuticals (Basel); 2018 Apr; 11(2):. PubMed ID: 29710851
[TBL] [Abstract][Full Text] [Related]
5. Effects of short-term metformin treatment on insulin sensitivity of blood glucose and free fatty acids.
Iannello S; Camuto M; Cavaleri A; Milazzo P; Pisano MG; Bellomia D; Belfiore F
Diabetes Obes Metab; 2004 Jan; 6(1):8-15. PubMed ID: 14686957
[TBL] [Abstract][Full Text] [Related]
6. Elevated Plasma Free Fatty Acid Susceptible to Early Cognitive Impairment in Type 2 Diabetes Mellitus.
Zhu W; Xu L; Zhang H; Tian S; An K; Cao W; Shi J; Tang W; Wang S
J Alzheimers Dis; 2021; 82(3):1345-1356. PubMed ID: 34151809
[TBL] [Abstract][Full Text] [Related]
7. Modeling the dynamics of glucose, insulin, and free fatty acids with time delay: The impact of bariatric surgery on type 2 diabetes mellitus.
Murillo AL; Li JX; Castillo-Chavez C
Math Biosci Eng; 2019 Jun; 16(5):5765-5787. PubMed ID: 31499737
[TBL] [Abstract][Full Text] [Related]
8. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G
Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
[TBL] [Abstract][Full Text] [Related]
9. Glycated lysine-141 in haptoglobin improves the diagnostic accuracy for type 2 diabetes mellitus in combination with glycated hemoglobin HbA
Spiller S; Li Y; Blüher M; Welch L; Hoffmann R
Clin Proteomics; 2017; 14():10. PubMed ID: 28360826
[TBL] [Abstract][Full Text] [Related]
10. Hsa_circ_0054633 in peripheral blood can be used as a diagnostic biomarker of pre-diabetes and type 2 diabetes mellitus.
Zhao Z; Li X; Jian D; Hao P; Rao L; Li M
Acta Diabetol; 2017 Mar; 54(3):237-245. PubMed ID: 27878383
[TBL] [Abstract][Full Text] [Related]
11. [Vascular endothelial function and plasma free fatty acids in the high-risk population of type 2 diabetes].
Chen SC; Ma HJ; Song GY
Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):114-7. PubMed ID: 17445435
[TBL] [Abstract][Full Text] [Related]
12. Association of plasma free fatty acids levels with the presence and severity of coronary and carotid atherosclerotic plaque in patients with type 2 diabetes mellitus.
Zhang MH; Cao YX; Wu LG; Guo N; Hou BJ; Sun LJ; Guo YL; Wu NQ; Dong Q; Li JJ
BMC Endocr Disord; 2020 Oct; 20(1):156. PubMed ID: 33087077
[TBL] [Abstract][Full Text] [Related]
13. Decreased free fatty acid levels associated with adverse clinical outcomes in coronary artery disease patients with type 2 diabetes: findings from the PRACTICE study.
Pan Y; Wu TT; Mao XF; Hou XG; Yang Y; Deng CJ; Wang S; Zheng YY; Xie X
Eur J Prev Cardiol; 2023 Jun; 30(8):730-739. PubMed ID: 36912007
[TBL] [Abstract][Full Text] [Related]
14. The Diagnostic Value of Whole Blood lncRNA ENST00000550337.1 for Pre-Diabetes and Type 2 Diabetes Mellitus.
Li X; Zhao Z; Gao C; Rao L; Hao P; Jian D; Li W; Tang H; Li M
Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):377-383. PubMed ID: 28407663
[TBL] [Abstract][Full Text] [Related]
15. New insights from continuous glucose monitoring into the route to diabetes.
Colas A; Vigil L; Rodríguez de Castro C; Vargas B; Varela M
Diabetes Metab Res Rev; 2018 Jul; 34(5):e3002. PubMed ID: 29516622
[TBL] [Abstract][Full Text] [Related]
16. Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis.
Liu L; Li Y; Guan C; Li K; Wang C; Feng R; Sun C
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2817-25. PubMed ID: 20846914
[TBL] [Abstract][Full Text] [Related]
17. Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients.
Al Jobori H; Daniele G; Adams J; Cersosimo E; Triplitt C; DeFronzo RA; Abdul-Ghani M
Diabetes Obes Metab; 2017 Jun; 19(6):809-813. PubMed ID: 28128510
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.
Luo P; Yu H; Zhao X; Bao Y; Hong CS; Zhang P; Tu Y; Yin P; Gao P; Wei L; Zhuang Z; Jia W; Xu G
J Proteome Res; 2016 Apr; 15(4):1288-99. PubMed ID: 26889720
[TBL] [Abstract][Full Text] [Related]
19. Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes.
I S Sobczak A; A Blindauer C; J Stewart A
Nutrients; 2019 Aug; 11(9):. PubMed ID: 31466350
[TBL] [Abstract][Full Text] [Related]
20. Differentially expressed haptoglobin as a potential biomarker for type 2 diabetic mellitus in Hispanic population.
Liu Z; Feng D; Gu D; Zheng R; Esperat C; Gao W
Biofactors; 2017 May; 43(3):424-433. PubMed ID: 28218436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
